Clinical trials
Trials in Oman
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
148 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 11 |
| 2019 | 6 |
| 2020 | 10 |
| 2021 | 15 |
| 2022 | 13 |
| 2023 | 13 |
| 2024 | 11 |
| 2025 | 15 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Recruiting | 19 |
| Not yet recruiting | 15 |
| Unknown status | 13 |
| Terminated | 11 |
| Active, not recruiting | 10 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sultan Qaboos University | 34 |
| Novartis Pharmaceuticals | 16 |
| Oman Ministry of Health | 13 |
| Oman Medical Speciality Board | 9 |
| Pfizer | 9 |
| AstraZeneca | 8 |
| Hoffmann-La Roche | 6 |
| Novo Nordisk A/S | 6 |
| Bayer | 4 |
| Sanofi | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 21 |
| Hemophilia A | 7 |
| Vaso-Occlusive Crises | 7 |
| Breast Neoplasms | 6 |
| Hematologic Diseases | 5 |
| Anxiety Disorders | 4 |
| Asthma | 4 |
| COVID-19 | 4 |
| Emergencies | 4 |
| Hemophilia B | 4 |
Trials
Showing 1 to 25 of 148. Each trial links to its page on Pharma Observatory.
48 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.